234 related articles for article (PubMed ID: 10867024)
1. Ligand discrimination in signaling through an ErbB4 receptor homodimer.
Sweeney C; Lai C; Riese DJ; Diamonti AJ; Cantley LC; Carraway KL
J Biol Chem; 2000 Jun; 275(26):19803-7. PubMed ID: 10867024
[TBL] [Abstract][Full Text] [Related]
2. ErbB2 and ErbB3 do not quantitatively modulate ligand-induced ErbB4 tyrosine phosphorylation.
Feroz K; Williams E; Riese DJ
Cell Signal; 2002 Sep; 14(9):793-8. PubMed ID: 12034361
[TBL] [Abstract][Full Text] [Related]
3. Betacellulin activates the epidermal growth factor receptor and erbB-4, and induces cellular response patterns distinct from those stimulated by epidermal growth factor or neuregulin-beta.
Riese DJ; Bermingham Y; van Raaij TM; Buckley S; Plowman GD; Stern DF
Oncogene; 1996 Jan; 12(2):345-53. PubMed ID: 8570211
[TBL] [Abstract][Full Text] [Related]
4. ErbB2 expression increases the spectrum and potency of ligand-mediated signal transduction through ErbB4.
Wang LM; Kuo A; Alimandi M; Veri MC; Lee CC; Kapoor V; Ellmore N; Chen XH; Pierce JH
Proc Natl Acad Sci U S A; 1998 Jun; 95(12):6809-14. PubMed ID: 9618494
[TBL] [Abstract][Full Text] [Related]
5. Differential signaling by the epidermal growth factor-like growth factors neuregulin-1 and neuregulin-2.
Crovello CS; Lai C; Cantley LC; Carraway KL
J Biol Chem; 1998 Oct; 273(41):26954-61. PubMed ID: 9756944
[TBL] [Abstract][Full Text] [Related]
6. The Q43L mutant of neuregulin 2β is a pan-ErbB receptor antagonist.
Wilson KJ; Mill CP; Gallo RM; Cameron EM; VanBrocklin H; Settleman J; Riese DJ
Biochem J; 2012 Apr; 443(1):133-44. PubMed ID: 22216880
[TBL] [Abstract][Full Text] [Related]
7. Replacement of N-terminal portions of TGF-alpha with corresponding heregulin sequences affects ligand-induced receptor signaling and intoxication of tumor cells by chimeric growth-factor toxins.
Schmidt M; Wels W
Int J Cancer; 2002 Jan; 97(3):349-56. PubMed ID: 11774287
[TBL] [Abstract][Full Text] [Related]
8. Prolactin and ErbB4/HER4 signaling interact via Janus kinase 2 to induce mammary epithelial cell gene expression differentiation.
Muraoka-Cook RS; Sandahl M; Hunter D; Miraglia L; Earp HS
Mol Endocrinol; 2008 Oct; 22(10):2307-21. PubMed ID: 18653779
[TBL] [Abstract][Full Text] [Related]
9. The oncogenic ErbB-2/ErbB-3 heterodimer is a surrogate receptor of the epidermal growth factor and betacellulin.
Pinkas-Kramarski R; Lenferink AE; Bacus SS; Lyass L; van de Poll ML; Klapper LN; Tzahar E; Sela M; van Zoelen EJ; Yarden Y
Oncogene; 1998 Mar; 16(10):1249-58. PubMed ID: 9546426
[TBL] [Abstract][Full Text] [Related]
10. Ligand discrimination by ErbB receptors: differential signaling through differential phosphorylation site usage.
Sweeney C; Carraway KL
Oncogene; 2000 Nov; 19(49):5568-73. PubMed ID: 11114736
[TBL] [Abstract][Full Text] [Related]
11. A natural ErbB4 isoform that does not activate phosphoinositide 3-kinase mediates proliferation but not survival or chemotaxis.
Kainulainen V; Sundvall M; Määttä JA; Santiestevan E; Klagsbrun M; Elenius K
J Biol Chem; 2000 Mar; 275(12):8641-9. PubMed ID: 10722704
[TBL] [Abstract][Full Text] [Related]
12. ErbB receptor-induced activation of stat transcription factors is mediated by Src tyrosine kinases.
Olayioye MA; Beuvink I; Horsch K; Daly JM; Hynes NE
J Biol Chem; 1999 Jun; 274(24):17209-18. PubMed ID: 10358079
[TBL] [Abstract][Full Text] [Related]
13. The extracellular region of ErbB4 adopts a tethered conformation in the absence of ligand.
Bouyain S; Longo PA; Li S; Ferguson KM; Leahy DJ
Proc Natl Acad Sci U S A; 2005 Oct; 102(42):15024-9. PubMed ID: 16203964
[TBL] [Abstract][Full Text] [Related]
14. ErbB4 expression in neural progenitor cells (ST14A) is necessary to mediate neuregulin-1beta1-induced migration.
Gambarotta G; Garzotto D; Destro E; Mautino B; Giampietro C; Cutrupi S; Dati C; Cattaneo E; Fasolo A; Perroteau I
J Biol Chem; 2004 Nov; 279(47):48808-16. PubMed ID: 15355992
[TBL] [Abstract][Full Text] [Related]
15. Kinase activator-receiver preference in ErbB heterodimers is determined by intracellular regions and is not coupled to extracellular asymmetry.
Ward MD; Leahy DJ
J Biol Chem; 2015 Jan; 290(3):1570-9. PubMed ID: 25468910
[TBL] [Abstract][Full Text] [Related]
16. Growth hormone-induced phosphorylation of epidermal growth factor (EGF) receptor in 3T3-F442A cells. Modulation of EGF-induced trafficking and signaling.
Huang Y; Kim SO; Jiang J; Frank SJ
J Biol Chem; 2003 May; 278(21):18902-13. PubMed ID: 12642595
[TBL] [Abstract][Full Text] [Related]
17. Cell death induced by TNF or serum starvation is independent of ErbB receptor signaling in MCF-7 breast carcinoma cells.
Egeblad M; Jäättelä M
Int J Cancer; 2000 Jun; 86(5):617-25. PubMed ID: 10797281
[TBL] [Abstract][Full Text] [Related]
18. Biological response to ErbB ligands in nontransformed cell lines correlates with a specific pattern of receptor expression.
Sundaresan S; Roberts PE; King KL; Sliwkowski MX; Mather JP
Endocrinology; 1998 Dec; 139(12):4756-64. PubMed ID: 9832411
[TBL] [Abstract][Full Text] [Related]
19. Epidermal growth factor (EGF)-like repeats of human tenascin-C as ligands for EGF receptor.
Swindle CS; Tran KT; Johnson TD; Banerjee P; Mayes AM; Griffith L; Wells A
J Cell Biol; 2001 Jul; 154(2):459-68. PubMed ID: 11470832
[TBL] [Abstract][Full Text] [Related]
20. secErbB4-26/549 antagonizes ligand-induced ErbB4 tyrosine phosphorylation.
Gilmore JL; Riese DJ
Oncol Res; 2004; 14(11-12):589-602. PubMed ID: 15667000
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
